Home
Radiopharm Theranostics Limited
RAD receives approval for Phase 1 therapeutic study of NSCLC
Business
Oct 9 2023
4 min read

RAD receives approval for Phase 1 therapeutic study of NSCLC

news images

Radiopharm Theranostics Ltd has released a press release.

View Attachment